| Primary |
| Pancreatitis Acute |
21.9% |
| Pneumonia |
14.1% |
| Prostate Cancer |
9.4% |
| Infection |
8.6% |
| Sepsis |
7.0% |
| Pyrexia |
3.9% |
| Upper Respiratory Tract Infection |
3.9% |
| Benign Prostatic Hyperplasia |
3.1% |
| Cough |
3.1% |
| Epilepsy |
3.1% |
| Gastritis |
3.1% |
| Hypokalaemia |
3.1% |
| Rash |
3.1% |
| Diarrhoea |
2.3% |
| Lung Infection |
2.3% |
| Acinetobacter Infection |
1.6% |
| Anaesthesia |
1.6% |
| Hypertension |
1.6% |
| Infectious Peritonitis |
1.6% |
| Pneumonia Bacterial |
1.6% |
|
| Anaphylactic Shock |
22.5% |
| Interstitial Lung Disease |
10.0% |
| Coagulopathy |
7.5% |
| Gastrointestinal Haemorrhage |
7.5% |
| Platelet Count Decreased |
7.5% |
| Henoch-schonlein Purpura |
5.0% |
| Rash |
5.0% |
| Vitamin K Deficiency |
5.0% |
| Blood Urea Increased |
2.5% |
| Convulsion |
2.5% |
| Death |
2.5% |
| Dyspnoea |
2.5% |
| Encephalopathy |
2.5% |
| Epilepsy |
2.5% |
| Gastric Haemorrhage |
2.5% |
| Gingival Bleeding |
2.5% |
| Haemorrhage |
2.5% |
| Heart Rate Increased |
2.5% |
| Hypoprothrombinaemia |
2.5% |
| International Normalised Ratio Increased |
2.5% |
|
| Secondary |
| Pneumonia |
13.4% |
| Product Used For Unknown Indication |
8.7% |
| Sepsis |
8.7% |
| Mediastinitis |
8.1% |
| Infection |
6.0% |
| Acinetobacter Infection |
5.4% |
| Anti-infective Therapy |
5.4% |
| Candidiasis |
5.4% |
| Lung Infection |
4.7% |
| Cough |
4.0% |
| Pyrexia |
4.0% |
| Upper Gastrointestinal Haemorrhage |
4.0% |
| Drug Use For Unknown Indication |
3.4% |
| Pulmonary Tuberculosis |
3.4% |
| Cardiac Failure Congestive |
2.7% |
| Cerebral Infarction |
2.7% |
| Hypertonic Bladder |
2.7% |
| Lung Infection Pseudomonal |
2.7% |
| Productive Cough |
2.7% |
| Asthma |
2.0% |
|
| Dermatitis Bullous |
10.0% |
| International Normalised Ratio Increased |
10.0% |
| Renal Failure Chronic |
10.0% |
| Anaphylactic Shock |
7.5% |
| Coagulopathy |
5.0% |
| Drug Ineffective |
5.0% |
| Haemorrhage |
5.0% |
| Hepatic Function Abnormal |
5.0% |
| Hypernatraemia |
5.0% |
| Proteus Test Positive |
5.0% |
| Pulmonary Tuberculosis |
5.0% |
| Pyrexia |
5.0% |
| Renal Failure |
5.0% |
| Diarrhoea |
2.5% |
| Encephalopathy |
2.5% |
| Epidermal Necrosis |
2.5% |
| Epilepsy |
2.5% |
| Gingival Bleeding |
2.5% |
| Heart Rate Increased |
2.5% |
| Hypersensitivity |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
45.9% |
| Acute Myeloid Leukaemia |
11.4% |
| Prophylaxis |
5.8% |
| Aplastic Anaemia |
4.8% |
| Product Used For Unknown Indication |
4.1% |
| Psoriatic Arthropathy |
3.2% |
| Cardiac Failure Congestive |
2.9% |
| Hypertension |
2.9% |
| Renal Cell Carcinoma |
2.9% |
| Pneumonia |
2.2% |
| Bone Marrow Conditioning Regimen |
2.1% |
| Infection |
1.9% |
| Gastrointestinal Infection |
1.6% |
| Infection Prophylaxis |
1.3% |
| Bile Duct Stone |
1.2% |
| Cytomegalovirus Infection |
1.2% |
| Pancytopenia |
1.2% |
| Insomnia |
1.1% |
| Nutritional Support |
1.1% |
| Ill-defined Disorder |
1.0% |
|
| Pulmonary Embolism |
17.5% |
| Sepsis |
11.1% |
| Delirium |
6.3% |
| Blood Creatinine Increased |
4.8% |
| Febrile Neutropenia |
4.8% |
| Pleural Effusion |
4.8% |
| Pyrexia |
4.8% |
| Tachypnoea |
4.8% |
| Thrombocytopenia |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Bile Duct Stone |
3.2% |
| Brain Oedema |
3.2% |
| Cardiomyopathy |
3.2% |
| Catheter Related Infection |
3.2% |
| Completed Suicide |
3.2% |
| Drug Ineffective |
3.2% |
| Hepatic Function Abnormal |
3.2% |
| Histiocytosis Haematophagic |
3.2% |
| Influenza |
3.2% |
| Lung Adenocarcinoma |
3.2% |
|
| Interacting |
| Vasodilatation |
21.4% |
| Bronchospasm |
14.3% |
| Cardiac Failure |
14.3% |
| Lung Infection |
14.3% |
| Polyuria |
14.3% |
| Coronary Artery Disease |
7.1% |
| Hypertension |
7.1% |
| Thrombocytopenia |
7.1% |
|
| Loss Of Consciousness |
50.0% |
| Platelet Count Decreased |
50.0% |
|
